These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 7716704)

  • 1. The cytokine network in the pathogenesis of systemic lupus erythematosus and possible therapeutic implications.
    Horwitz DA; Jacob CO
    Springer Semin Immunopathol; 1994; 16(2-3):181-200. PubMed ID: 7716704
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphocytes, cytokines, inflammation, and immune trafficking.
    Tsokos GC
    Curr Opin Rheumatol; 1994 Sep; 6(5):461-7. PubMed ID: 7993702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do cytokines play a role in systemic lupus erythematosus?
    Singh AK
    J R Coll Physicians Lond; 1992 Oct; 26(4):374-6. PubMed ID: 1432876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines and their receptors as biomarkers of systemic lupus erythematosus.
    Suh CH; Kim HA
    Expert Rev Mol Diagn; 2008 Mar; 8(2):189-98. PubMed ID: 18366305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Novel therapeutic possibilities in systemic lupus erythematosus].
    Bazsó A; Poór G; Gergely P; Kiss E
    Orv Hetil; 2010 May; 151(18):735-40. PubMed ID: 20410000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine polymorphisms in systemic lupus erythematosus and Sjögren's syndrome.
    Magnusson V; Nakken B; Bolstad AI; Alarcón-Riquelme ME
    Scand J Immunol; 2001; 54(1-2):55-61. PubMed ID: 11439148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the cytokine profile of lupus-prone mice (NZB/NZW)F1 induced by Plasmodium chabaudi and their implications in the reversal of clinical symptoms.
    Sato MN; Minoprio P; Avrameas S; Ternynck T
    Clin Exp Immunol; 2000 Feb; 119(2):333-9. PubMed ID: 10632672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines in systemic lupus erythematosus.
    Poole BD; Niewold TB; Tsokos GC; Via CS
    J Biomed Biotechnol; 2010; 2010():735169. PubMed ID: 21603232
    [No Abstract]   [Full Text] [Related]  

  • 9. Aberrant cytokine gene expression in the hippocampus in murine systemic lupus erythematosus.
    Tomita M; Holman BJ; Santoro TJ
    Neurosci Lett; 2001 Apr; 302(2-3):129-32. PubMed ID: 11290404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cytokines in the immunopathogenesis of lupus.
    Handwerger BS; Rus V; da Silva L; Via CS
    Springer Semin Immunopathol; 1994; 16(2-3):153-80. PubMed ID: 7716703
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene therapy in systemic lupus erythematosus.
    Kyttaris VC; Juang YT; Tsokos GC
    Lupus; 2004; 13(5):353-8. PubMed ID: 15230292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous lupus erythematosus: understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies.
    Lee HJ; Sinha AA
    Autoimmunity; 2006 Sep; 39(6):433-44. PubMed ID: 17060022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effect of human amniotic epithelial cells in murine models of Hashimoto's thyroiditis and Systemic lupus erythematosus.
    Tan B; Yuan W; Li J; Yang P; Ge Z; Liu J; Qiu C; Zhu X; Qiu C; Lai D; Guo L; Wang L; Yu L
    Cytotherapy; 2018 Oct; 20(10):1247-1258. PubMed ID: 30174233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biological therapies of systemic lupus erythematosus].
    Olesińska M; Chwalińska-Sadowska H; Mielnik P; Wiesik-Szewczyk E
    Pol Merkur Lekarski; 2006 Mar; 20(117):371-3. PubMed ID: 16780279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines in the pathophysiology of systemic lupus erythematosus.
    Goldman M
    Autoimmunity; 1990; 8(2):173-9. PubMed ID: 2104189
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent advances in cytokines in cutaneous and systemic lupus erythematosus.
    Mikita N; Ikeda T; Ishiguro M; Furukawa F
    J Dermatol; 2011 Sep; 38(9):839-49. PubMed ID: 21767292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fli-1, a Functional Factor Performed in Autoimmune Lupus.
    Xu WD; Zhang M; Zhao Y; Liu Y
    Inflammation; 2016 Feb; 39(1):493-498. PubMed ID: 26424096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of systemic lupus erythematosus--studies using disease models. 1. The effect of MHC on lupus nephritis in (NZB x NZW)F1--a therapeutic suggestion].
    Sato H; Hirose S; Shirai S
    Nihon Rinsho; 1984 Dec; 42(12):2791-5. PubMed ID: 6530763
    [No Abstract]   [Full Text] [Related]  

  • 19. Emerging biological drugs: a new therapeutic approach for Systemic Lupus Erythematosus. An update upon efficacy and adverse events.
    Murdaca G; Colombo BM; Puppo F
    Autoimmun Rev; 2011 Nov; 11(1):56-60. PubMed ID: 21835271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune cells and cytokines in systemic lupus erythematosus: an update.
    Kyttaris VC; Juang YT; Tsokos GC
    Curr Opin Rheumatol; 2005 Sep; 17(5):518-22. PubMed ID: 16093827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.